Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study.
Flisiak R, Janczewska E, Łucejko M, Karpińska E, Zarębska-Michaluk D, Nazzal K, Bolewska B, Białkowska J, Berak H, Fleischer-Stępniewska K, Tomasiewicz K, Karwowska K, Simon K, Piekarska A, Tronina O, Tuchendler E, Garlicki A. Flisiak R, et al. Among authors: nazzal k. J Viral Hepat. 2018 Nov;25(11):1298-1305. doi: 10.1111/jvh.12945. Epub 2018 Jul 3. J Viral Hepat. 2018. PMID: 29888828
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study.
Flisiak R, Janczewska E, Wawrzynowicz-Syczewska M, Jaroszewicz J, Zarębska-Michaluk D, Nazzal K, Bolewska B, Bialkowska J, Berak H, Fleischer-Stępniewska K, Tomasiewicz K, Karwowska K, Rostkowska K, Piekarska A, Tronina O, Madej G, Garlicki A, Lucejko M, Pisula A, Karpińska E, Kryczka W, Wiercińska-Drapało A, Mozer-Lisewska I, Jabłkowski M, Horban A, Knysz B, Tudrujek M, Halota W, Simon K. Flisiak R, et al. Among authors: nazzal k. Aliment Pharmacol Ther. 2016 Nov;44(9):946-956. doi: 10.1111/apt.13790. Epub 2016 Sep 9. Aliment Pharmacol Ther. 2016. PMID: 27611776 Clinical Trial.
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study.
Simon KA, Flisiak R, Łapiński TW, Janczewska E, Wawrzynowicz-Syczewska M, Jaroszewicz J, Zarębska-Michaluk D, Nazzal K, Bolewska B, Białkowska J, Berak H, Fleischer-Stępniewska K, Tomasiewicz K, Karwowska K, Rostkowska KA, Piekarska A, Tronina O, Madej G, Garlicki A, Łucejko M, Pisula A, Karpińska E, Kryczka W, Wiercińska-Drapało A, Mozer-Lisewska I, Jabłkowski MS, Horban A, Knysz B, Tudrujek M, Halota W. Simon KA, et al. Among authors: nazzal k. Clin Exp Hepatol. 2019 Sep;5(3):215-223. doi: 10.5114/ceh.2019.87634. Epub 2019 Sep 5. Clin Exp Hepatol. 2019. PMID: 31598558 Free PMC article.
Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
Caraballo Cortés K, Osuch S, Perlejewski K, Pawełczyk A, Kaźmierczak J, Janiak M, Jabłońska J, Nazzal K, Stelmaszczyk-Emmel A, Berak H, Bukowska-Ośko I, Paciorek M, Laskus T, Radkowski M. Caraballo Cortés K, et al. Among authors: nazzal k. J Viral Hepat. 2019 Aug;26(8):942-950. doi: 10.1111/jvh.13108. Epub 2019 Apr 29. J Viral Hepat. 2019. PMID: 30972915 Free PMC article.
[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)].
Juszczyk J, Baka-Cwierz B, Beniowski M, Berak H, Bolewska B, Boroń-Kaczmarska A, Cianciara J, Cieśla A, Dziambor A, Gasiorowski J, Gietka A, Gliwińska E, Gładysz A, Gonciarz Z, Halota W, Horban A, Inglot M, Janas-Skulina U, Janczewska-Kazek E, Jaskowska J, Jurczyk K, Knysz B, Kryczka W, Kuydowicz J, Lakomy EA, Logiewa-Bazger B, Lyczak A, Mach T, Mazur W, Michalska Z, Modrzewska R, Nazzal K, Pabjan P, Piekarska A, Piszko P, Sikorska K, Szamotulska K, Sliwińska M, Swietek K, Tomasiewicz K, Topczewska-Staubach E, Trocha H, Wasilewski M, Wawrzynowicz-Syczewska M, Wrodycki W, Zarebska-Michaluk D, Zejc-Bajsarowicz M. Juszczyk J, et al. Among authors: nazzal k. Przegl Epidemiol. 2005;59(3):651-60. Przegl Epidemiol. 2005. PMID: 16433307 Clinical Trial. Polish.
[Peginterferon alpha-2b in patients with chronic hepatitis C].
Juszczyk J, Białkowska J, Bolewska B, Boroń-Kaczmarska A, Gładysz A, Halota W, Inglot M, Janas-Skulina U, Jabłkowski M, Jabłonska J, Jurczyk K, Kryczka W, Kuydowicz J, Lakomy EA, Lyczak A, Mach T, Michalska Z, Moczko J, Modrzewska R, Nazzal K, Pabjan P, Pawłowska M, Piszko P, Sikorska K, Swiqtek K, Tomasiewicz K, Topczewska-Staubach E, Wawrzynowicz-Syczewska M, Zarqbska-Michaluk D, Zejc-Bajsarowicz M. Juszczyk J, et al. Among authors: nazzal k. Pol Merkur Lekarski. 2004 Apr;16(94):353-7. Pol Merkur Lekarski. 2004. PMID: 15517932 Clinical Trial. Polish.
17 results